Find and Pitch Jounalists, Get Your Story Covered

Tags: Hematology Breast Cancer

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis - about 2 months ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 5 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - about 1 year ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation - about 2 months ago Mezigdomide Combinations Show Promise in Multiple Myeloma - about 2 months ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 8 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - about 1 year ago Why Some Myeloma Patients Refuse Stem Cell Transplant - about 1 year ago
3	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies - about 2 months ago Final Thoughts - 3 months ago Personalizing Treatments and Patient Education - 4 months ago Real-World Considerations for New Therapies - 4 months ago Impact of Transplant Eligibility on Treatment Selection - 5 months ago
4	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Circumventing Cancer Resistance - 2 months ago New Research Avenues Provide Hope for Metastatic Disease - 11 months ago
5	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	What Drives Myeloid Cell Responses to Disease - 2 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - 2 months ago GSK Multiple Myeloma Drug’s DREAMM Comeback Continues With Phase 3 Data at ASH - 3 months ago FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 6 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 3 months ago Arcellx to present positive data on multiple myeloma treatments - 4 months ago Scotland first in UK to approve new myeloma treatment - 6 months ago
8	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 3 months ago Current Landscape of Bispecific Therapies for RRMM - 3 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 4 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 4 months ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 11 months ago

Journalists covering Multiple Myeloma ,oncology,hematology,resistance,relapsed refractory multiple myeloma,mutations